Anchor Molecular

We focus on liquid biopsy cancer diagnostic test based on cell-free DNA (cfDNA) and circulating tumor DNA (ctDNA). Our mission is to provide the highest quality products for genetic testing at costs that will enable accelerated adaptation of liquid biopsy testing worldwide. Our founders have 20 years of experience in in-vitro diagnostics (IVD), molecular control development, and manufacturing. We are experts in providing accurate, stable, traceable, affordable reference standards for molecular tests based on NGS, qPCR and ddPCR. Our unique standards and controls are based on true human plasma allowing them to mimic human specimens and bring a higher level of confidence to liquid assay testing results. About Us